Skip to main content
  • Oral presentation
  • Open access
  • Published:

Interleukin-37 as fundamental inhibitor of innate immunity

The interleukin-1 (IL-1) family of ligands has 11 members of which most are proinflammatory. The receptors, signaling pathways, and functions of the classical family members (IL-1α, IL-1β and IL-18) have been studied extensively. However, knowledge of Interleukin-37 (IL-37/IL-1F7), which was first identified by in silico research in 2000 remains limited.

IL-37 shares critical amino acid residues with IL-18 and binds to the IL-18-binding protein enhancing its ability to inhibit IL-18-induced interferon-γ. Data suggest that IL-37 also binds to the IL-18Rα and, for its anti-inflammatory properties, likely recruits an accessory receptor chain with inhibitory properties, such as the single Ig IL-1 related receptor. We recently reported that overexpression of IL-37 in cells of monocytic or epithelial origin almost completely abolishes the production of proinflammatory cytokines as IL-1α/β, TNFα, IL-6 and IL-8 in response to TLR-ligands or IL-1β. Anti-inflammatory cytokines were unaffected. Vice versa, functional knockdown of IL-37 in primary human cells by siRNA increased the production of proinflammatory cytokines. IL-37tg mice are protected against LPS-induced shock. Thus IL-37 is a fundamental inhibitor of innate immune responses.

IL-37 protein is expressed in human monocytes and upregulated by LPS. Similarly to IL-1α and IL-33, IL-37 is expressed intracellularly and translocates to the nucleus upon cell stimulation in a caspase-1 dependent manner. IL-37 interacts inside the cell with Smad3 and inflammation in IL-37tg mice is increased when endogenous Smad3 is depleted. IL-37 is also secreted in the supernatant of stimulated transfected cells or peripheral mononuclear blood cells. However, the extracellular functionality of IL-37 is still elusive.

Author information

Authors and Affiliations

Authors

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Cite this article

Bufler, P. Interleukin-37 as fundamental inhibitor of innate immunity. Arthritis Res Ther 13 (Suppl 2), O15 (2011). https://doi.org/10.1186/ar3419

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/ar3419

Keywords